Laboratory monitoring of which of the following is desirable with low molecular weight heparin therapy: March 2012
Correct Answer: Anti-factor Xa activity
Description: Ans: D i.e. anti-factor Xa activity Laboratory monitoring of anticoagulant LMW heparin selectively inhibit factor Xa with little effect on Ha. So LMW heparins have smaller effect on aPTT and whole blood clotting time. Since aPTT/clotting times are not prolonged, laboratory monitoring is not needed LMWH therapy is monitored by the anti-factor Xa assay, measuring anti-factor Xa activity.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now